EconPapers    
Economics at your fingertips  
 

Predicting rapid progression phases in glaucoma using a soft voting ensemble classifier exploiting Kalman filtering

Isaac A. Jones (), Mark P. Van Oyen (), Mariel S. Lavieri (), Christopher A. Andrews () and Joshua D. Stein ()
Additional contact information
Isaac A. Jones: University of Michigan
Mark P. Van Oyen: University of Michigan
Mariel S. Lavieri: University of Michigan
Christopher A. Andrews: Kellogg Eye Institute
Joshua D. Stein: Kellogg Eye Institute

Health Care Management Science, 2021, vol. 24, issue 4, No 3, 686-701

Abstract: Abstract In managing patients with chronic diseases, such as open angle glaucoma (OAG), the case treated in this paper, medical tests capture the disease phase (e.g. regression, stability, progression, etc.) the patient is currently in. When medical tests have low residual variability (e.g. empirical difference between the patient’s true and recorded value is small) they can effectively, without the use of sophisticated methods, identify the patient’s current disease phase; however, when medical tests have moderate to high residual variability this may not be the case. This paper presents a framework for handling the latter case. The framework presented integrates the outputs of interacting multiple model Kalman filtering with supervised learning classification. The purpose of this integration is to estimate the true values of patients’ disease metrics by allowing for rapid and non-rapid phases; and dynamically adapting to changes in these values over time. We apply our framework to classifying whether a patient with OAG will experience rapid progression over the next two or three years from the time of classification. The performance (AUC) of our model increased by approximately 7% (increased from 0.752 to 0.819) when the Kalman filtering results were incorporated as additional features in the supervised learning model. These results suggest the combination of filters and statistical learning methods in clinical health has significant benefits. Although this paper applies our methodology to OAG, the methodology developed is applicable to other chronic conditions.

Keywords: Chronic diseases; Predictive modeling; Machine learning; Disease progression; Clinical decision making (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10729-021-09564-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:kap:hcarem:v:24:y:2021:i:4:d:10.1007_s10729-021-09564-2

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/10729

DOI: 10.1007/s10729-021-09564-2

Access Statistics for this article

Health Care Management Science is currently edited by Yasar Ozcan

More articles in Health Care Management Science from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:kap:hcarem:v:24:y:2021:i:4:d:10.1007_s10729-021-09564-2